Relapsing De Novo Membranous Nephropathy. (2nd May 2022)

• Record Type: Journal Article
• Authors: Ali, Ala; Al-Taee, Huda; Kadhim, Thaer J.
• Other Names: Grenda Ryszard Academic Editor.
• Is Part Of: Case reports in transplantation. Volume 2022(2022)
• Publication Date: 2022-05-02
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation; Transplantation of organs, tissues, etc; Periodicals; Periodicals; 617.954
• DOI: 10.1155/2022/6754520
• Languages: English
• ISSNs: 2090-6943

Abstract

Abstract : Allograft membranous glomerulopathy can be a recurrent or de novo disease. Both instead have different underlying immune pathophysiology and disease pattern. While the introduction of ANTI-PLAR2 and THS7A brought new insights into the management of Immune/primary MN, the treatment of de novo MN is not clear. Relapsing de novo MN in a kidney transplant was rarely reported. Here, we present a case of relapsing de novo MN without evidence of rejection and a gratifying response to rituximab.